Request Deal Involvement
ORI Capital, Longitude Capital and Decheng Capital led a $120m Series E funding round in CG Oncology.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
pr advisors
KKH Advisors
or
Principals
target
CG ONCOLOGY
bidder
ALLY BRIDGE GROUP
bidder
MALIN CORPORATION PLC
bidder
SIRONA CAPITAL
bidder
ORI CAPITAL
bidder
LONGITUDE CAPITAL MANAGEMENT CO LLC
bidder
DECHENG CAPITAL LLC
bidder
RA CAPITAL MANAGEMENT
bidder
ACORN BIOVENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite